Glycolysis and proteases as targets for the design of new anti-trypanosome drugs.

Current topics in medicinal chemistry

Volumn 2, Issue 5, 2002, Pages 439-456

  Lakhdar Ghazal, Faouzi ^a   Blonski, Casimir ^a   Willson, Michele ^a   Michels, Paul ^a   Perie, Jacques ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; ENZYME INHIBITOR; PROTEINASE INHIBITOR;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; GLYCOLYSIS; HUMAN; METABOLISM; REVIEW; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ENZYME INHIBITORS; GLYCOLYSIS; HUMANS; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA;

EID: 0036581901     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026024607472     Document Type: Review

References (132)